EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From Bench to Bedside: Clinical Translation of Electrochemical Biosensors for Viral Diagnostics

Hashim R. Felemban, Thamir A. Alandijany

Diagnostics · 19.11.2026 · 16 (22) · 3873

DOI: 10.3390/diagnostics16223873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 19.11.2026. Verfasst von Hashim R. Felemban und 1 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Electrochemical biosensors have emerged as promising platforms for rapid viral diagnostics, offering high analytical sensitivity, portability, short detection times, and potential compatibility with point-of-care testing. Advances in electrode nanostructuring, biorecognition strategies, signal amplification, and miniaturized instrumentation have enabled remarkably low limits of detection, reaching femtomolar and attomolar concentrations for synthetic viral targets under optimized experimental conditions. However, exceptional analytical performance under controlled conditions does not necessarily translate into clinical diagnostic utility. This review examines the progression of electrochemical biosensors from analytical proof-of-concept toward clinical application, emphasizing the evidence required for successful translation. Following a brief overview of viral targets, recognition strategies, and electrochemical detection approaches, particular attention is given to studies evaluating authentic clinical specimens, including those targeting SARS-CoV-2, dengue virus, human papillomavirus, and hepatitis C virus. Despite encouraging findings, clinical validation remains limited by small sample sizes, incomplete reporting of diagnostic sensitivity and specificity, and insufficient multicentre evaluation, while many platforms have been assessed only using artificial or spiked matrices. Additional challenges include matrix interference, biofouling, reproducibility, sample preparation, manufacturing consistency, stability, workflow integration, and regulatory requirements. Importantly, analytical limits of detection must be interpreted in relation to viral biology, specimen characteristics, clinically relevant thresholds, and intended clinical use. Future research should prioritize reproducible sample-to-answer performance over increasingly extreme analytical sensitivity. Accordingly, this review proposes a staged translational framework encompassing native-matrix analytical validation, adequately powered clinical studies, multicentre reproducibility, manufacturing and usability assessments, and regulatory evaluation. Ultimately, the clinical adoption of electrochemical biosensors will depend on robust evidence demonstrating reliable diagnostic performance in real-world healthcare settings.

Förderung

  • Deanship of Scientific Research (DSR) at King Abdulaziz University, Jeddah, Saudi Arabia

Zitieren

APA

Felemban, H. R., & Alandijany, T. A. (2026). From Bench to Bedside: Clinical Translation of Electrochemical Biosensors for Viral Diagnostics. Diagnostics, 16(22), 3873. https://doi.org/10.3390/diagnostics16223873

Vancouver

Felemban HR, Alandijany TA. From Bench to Bedside: Clinical Translation of Electrochemical Biosensors for Viral Diagnostics. Diagnostics. 2026;16(22):3873. doi:10.3390/diagnostics16223873

BibTeX
@article{Felemban2026,
  author = {Felemban, Hashim R. and Alandijany, Thamir A.},
  title = {From Bench to Bedside: Clinical Translation of Electrochemical Biosensors for Viral Diagnostics},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {22},
  pages = {3873},
  doi = {10.3390/diagnostics16223873}
}
Kostenlos starten →